Merck Frosst
Patients & Caregivers Contact Us Français
Patients & CaregiversContact UsFrançais
Home

ROTATEQ®

Press Releases

Jan 21, 2008 National Vaccine Advisory Committee Issues Recommended Use For RotaTeq®
Aug 23, 2006 RotaTeq™ Is Approved In Canada
May 04, 2006 Canadian Mirage Study Confirms Rotavirus As Severe Gastrointestinal Disease For Infants With Significant Impact On Parents
Jan 05, 2006 Merck's Investigational Rotavirus Vaccine Effectively Protects Infants Against Severe Rotavirus Disease

Product Monograph / Prescribing Information / Product Information

Click here

Studies

Disease Fact Sheets

Aug 23, 2006 Rotavirus Gastroenteritis

Product Fact Sheets

Aug 23, 2006 RotaTeq™ (rotavirus vaccine, live, oral, pentavalent)

Photos

B-Roll

August 23, 2006 Announcement related to Health Canada's approval of RotaTeq™

If you wish to receive a copy of the b-roll, please contact our Public Relations Department at (514) 428-3494.

What's New
Contact
Media contacts.
Printer friendly

This site is for residents of Canada. / This site was updated on May 2, 2008.